Stamford, CT -- (SBWIRE) -- 11/02/2013 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Rite Aid Corporation (NYSE:RAD), Merrimack Pharmaceuticals Inc (NASDAQ:MACK), Molycorp Inc (NYSE:MCP), JPMorgan Chase & Co. (NYSE:JPM)
Rite Aid Corporation (NYSE:RAD) ended lower -1.13% from its previous close of $5.33 and complete the day at $5.27. The total number of shares changed hands during the day was 26.48 million. After opening at $5.37, the stock hit as high as $5.40. However, it traded between $0.95 and $5.44 over the last twelve months.
Stocks graphical chart shows a bullish trend during its last one month’s trading session. It remained positive +287.5% during the previous three months trade. Rite Aid Corporation, through its subsidiaries, operates a chain of retail drugstores in the United States. The company sells prescription drugs and a range of other merchandise, including over-the-counter medications, health and beauty aids, personal care items, cosmetics, household items, food and beverages, greeting cards, seasonal merchandise, and other everyday and convenience products.
Has RAD Found The Bottom and Ready To Move Up? Find Out Here
Merrimack Pharmaceuticals Inc (NASDAQ:MACK) closed yesterday at $2.44, a -8.96% decrease. Around 2.36 million shares were traded, beating an-average trading volume of 1.33 million shares. The company is now valued at around $249.39 million. The stock opened the session at $2.67 and touched its highest price point at $2.68.
MACK’s lowest price point for the session stood at $2.41 and its 52 week price range stood at $2.41 - $7.50. Merrimack Pharmaceuticals, Inc., a biopharmaceutical company, focuses on discovering, developing, and preparing to commercialize medicines paired with companion diagnostics for the treatment of cancer in the United States.
Has MACK Found The Bottom And Ready To Gain Momentum? Find Out Here
Molycorp Inc (NYSE:MCP) moved -0.99 percent lower at $5.02 and traded between $4.95 and $5.18 after opening the day at $5.07. Its performance over the last five days remained -4.02%, which stands at -4.02% for a month. Going back further than one month, 1-year performance after recent close was -46.82%.
The company has a total of 188.61 million outstanding shares and its total market capitalization is $946.81 million. Its beta value stands at 3.49 times and earnings per share was -$3.96. Molycorp, Inc. produces and sells rare earth and rare metal materials in the United States and internationally. The company?s Resources segment extracts rare earth minerals, including rare earth concentrates; rare earth oxides (REO), such as lanthanum, cerium, neodymium, praseodymium, and yttrium
Why Should Investors Buy MCP After the Recent Fall? Just Go Here and Find Out
JPMorgan Chase & Co. (NYSE:JPM)’s shares rose, +1.88 percent from its previous close of $51.54 to close at $52.51. The stock is up around +19.42% this year and +27.58% for the last 12 months. Around 25.80 million shares changed hands yesterday, higher from an-average trading volume of 22.73 million shares. JPMorgan Chase & Co., a financial holding company, provides various financial services worldwide. Its Consumer and Community Banking segment provides deposits, investment products and services, lending, and cash management and payment solutions to consumers and small businesses; mortgage origination and servicing; and residential mortgages and home equity loans.
Why Should Investors Buy JPM After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2013 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)